Opportunistic Infections Citation List:
November 12 - November 23, 2010
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial alphabeta region. Kondori, N., L. Baltzer, G.T. Dolphin, and I. Mattsby-Baltzer. International Journal of Antimicrobial Agents, 2010; [Epub ahead of print]. PMID[21075607].
[Pubmed]. OI_1112-112310.
2. Synthesis of new antifungal peptides selective against Cryptococcus neoformans. Grimaldi, M., M. De Rosa, S. Di Marino, M. Scrima, B. Posteraro, M. Sanguinetti, G. Fadda, A. Soriente, and A.M. D'Ursi. Bioorganic & Medicinal Chemistry Letters, 2010. 18(22): p. 7985-90; PMID[20943406].
[Pubmed]. OI_1112-112310.
3. Synthesis and antifungal activity of a novel series of 13-(4-isopropylbenzyl)berberine derivatives. Park, K.D., S.J. Cho, J.S. Moon, and S.U. Kim. Bioorganic & Medicinal Chemistry Letters, 2010. 20(22): p. 6551-4; PMID[20932752].
[Pubmed]. OI_1112-112310.
4. Synthesis and antifungal activity of benzofuran-5-ols. Ryu, C.K., A.L. Song, J.Y. Lee, J.A. Hong, J.H. Yoon, and A. Kim. Bioorganic & Medicinal Chemistry Letters, 2010. 20(22): p. 6777-80; PMID[20851600].
[Pubmed]. OI_1112-112310.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
5. Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin. Biava, M., G.C. Porretta, G. Poce, C. Battilocchio, S. Alfonso, A. De Logu, N. Serra, F. Manetti, and M. Botta. Bioorganic and Medicinal Chemistry, 2010. 18(22): p. 8076-84; PMID[20934344].
[Pubmed]. OI_1112-112310.
6. Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Frecer, V., P. Seneci, and S. Miertus. Journal of Computer-Aided Molecular Design, 2010; [Epub ahead of print]. PMID[21082329].
[Pubmed]. OI_1112-112310.
7. Novel Small Molecule Inhibitors of MDR Mycobacterium tuberculosis by NMR Fragment Screening of Antigen 85C. Scheich, C., V. Puetter, and M. Schade. Journal of Medicinal Chemistry, 2010; [Epub ahead of print]. PMID[21073150].
[Pubmed]. OI_1112-112310.
8. Identification of novel diphenyl urea inhibitors of Mt-Guab2 active against Mycobacterium tuberculosis. Usha, V., S.S. Gurcha, A. Lovering, A.J. Lloyd, A. Papaemmanouil, R.C. Reynolds, and G.S. Besra. Microbiology, 2010; [Epub ahead of print]. PMID[21081761]. [Pubmed]. OI_1112-112310.
Citations from the ISI Web of Knowledge Listings for O.I.
9. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors. Altaf, M., C.H. Miller, D.S. Bellows, and R. O'Toole. Tuberculosis, 2010. 90(6): p. 333-337; ISI[000283739000002].
[WOS]. OI_1112-112310.
10. Leads for antitubercular compounds from kinase inhibitor library screens. Magnet, S., R.C. Hartkoorn, R. Szekely, J. Pato, J.A. Triccas, P. Schneider, C. Szantai-Kis, L. Orfi, M. Chambon, D. Banfi, M. Bueno, G. Turcatti, G. Keri, and S.T. Cole. Tuberculosis, 2010. 90(6): p. 354-360; ISI[000283739000005].
[WOS]. OI_1112-112310.
11. Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity. Manikannan, R., R. Venkatesan, S. Muthusubramanian, P. Yogeeswari, and D. Sriram. Bioorganic & Medicinal Chemistry Letters, 2010. 20(23): p. 6920-6924; ISI[000283801400009].
[WOS]. OI_1112-112310.
12. Synthesis, Spectroscopic and Pharmacological Studies of Bivalent Copper, Zinc and Mercury Complexes of Thiourea. Parmar, S., Y. Kumar, and A. Mittal. South African Journal of Chemistry-Suid-Afrikaanse Tydskrif Vir Chemie, 2010. 63: p. 123-129; ISI[000283714900001].
[WOS]. OI_1112-112310.
13. In vitro inhibition of toxigenic filamentous fungi. Ramos, D.M.B., C.F. Silva, L.R. Batista, and R.F. Schwan. Acta Scientiarum Agronomy 2010. 32(3): p. 397-402; ISI[000283618900004].
[WOS]. OI_1112-112310.